Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05686317 · ClinicalTrials.gov registry record · NA
ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System
A NA study of Heart Failure, sponsored by Edwards Lifesciences.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 20
- Study locations
NCT05686317 is a NA study of Heart Failure that is active but no longer recruiting, run by Edwards Lifesciences. The registered enrollment target is 100 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (95% lower). The trial reports 20 study locations across 13 states.
The verdict
NCT05686317, a NA study of Heart Failure, is active but no longer recruiting, sponsored by Edwards Lifesciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a prospective, multi-center, randomized, sham-controlled, double-blinded (participant and outcomes assessor) clinical trial.
Conditions Studied
Interventions
- DEVICE Edwards APTURE transcatheter shunt system
- DIAGNOSTIC_TEST Sham procedure
Study Locations (20)
California
- University of California Irvine - Irvine
- University of California San Diego - La Jolla
- Scripps Health - La Jolla
- University of Southern California - Los Angeles
- University of California San Francisco - San Francisco
Minnesota
- Abbott Northwestern Hospital - Minneapolis
- Mayo Clinic - Rochester
New York
- St. Francis Hospital & Heart Center - Roslyn
- Montefiore Medical Center - The Bronx
Ohio
- The Christ Hospital - Cincinnati
- The Ohio State University - Columbus
Illinois
- Ascension Illinois Heart and Vascular Medical Group - Elk Grove
Kansas
- Kansas University Medical Center - Kansas City
Oklahoma
- Oklahoma Heart Institute - Tulsa
Oregon
- Oregon Health and Science University - Oregon City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2030-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05686317
The ClinicalTrials.gov registry entry for NCT05686317 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (95% lower). The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Edwards APTURE transcatheter shunt system is the first listed.
NCT05686317 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Minnesota, New York.
Frequently Asked Questions
What is clinical trial NCT05686317 about?
NCT05686317 is a clinical study titled "ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System". This is a prospective, multi-center, randomized, sham-controlled, double-blinded (participant and outcomes assessor) clinical trial.
What is the current status of trial NCT05686317?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-04-01. Estimated completion is 2030-08-31.
What conditions does trial NCT05686317 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT05686317?
The interventions under investigation include: Edwards APTURE transcatheter shunt system (DEVICE), Sham procedure (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05686317?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05686317 being conducted?
This trial has 20 study locations across California, Illinois, Kansas, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.